TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Medicine Pills And Tablets, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Medicine Pills And Tablets technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Medicine Pills And Tablets

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Industry Landscape Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Medicine Pills And Tablets industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Medicine Pills And Tablets industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Medicine Pills And Tablets industry

Modified Release Orally Administered Amino Acid FormulationsAPR APPLIED PHARMA RESEARCHJun 10, 2025MAIWALD
Compositions Of 1-(4-Bromo-5-(1-Ethyl-7-(Methylamino)-2-Oxo-1,2-Dihydro-1,6-Naphthyridin-3-Yl)-2-Fluorophenyl)-3-PhenylureaDECIPHERA PHARMACEUTICALSMay 28, 2025ALFRED E TIEFENBACHER
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMay 7, 2025SYNTHON
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMay 6, 2025SANDOZ
Compounds And Methods For Treatment Of Inflammatory Bowel Disease With Extra-Intestinal ManifestationsARENA PHARMACEUTICALSFeb 1, 2025TEVA PHARMACEUTICALS
Compounds And Methods For Treatment Of Inflammatory Bowel Disease With Extra-Intestinal ManifestationsARENA PHARMACEUTICALSJan 31, 2025MAIWALD
Novel Pharmaceutical CompositionNOVARTISJan 10, 2025KILBURN & STRODE
Pharmaceutical Composition, Pharmaceutical Dosage Form, Process For Their Preparation, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMJan 10, 2025MANSKE
Novel Pharmaceutical CompositionNOVARTISJan 9, 2025GALENICUM HEALTH SLU
Pharmaceutical Composition, Pharmaceutical Dosage Form, Process For Their Preparation, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMJan 8, 2025ELKINGTON AND FIFE

To stay ahead in the competitive Medicine Pills And Tablets industry, companies are constantly innovating. Here are the top patents facing oppositions in the Medicine Pills And Tablets industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM18
Nov 13, 2019Apixaban FormulationsBRISTOL MYERS SQUIBB IRELAND12
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA11
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA11
Aug 18, 2021Formulations Of EnzalutamideMEDIVATION PROSTATE THERAPEUTICS11
Dec 11, 2019Rapid Dissolution Formulation Of A Cinacalcet HclAMGEN11
Nov 27, 2019Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGEN10
Oct 16, 2019Apixaban FormulationsPFIZER10
Oct 16, 2019Apixaban FormulationsBRISTOL MYERS SQUIBB IRELAND10
Dec 5, 2018Apixaban FormulationsBRISTOL MYERS SQUIBB IRELAND UNLIMITED9